Abstract:Alzheimer's disease (AD) is a severe irreversible neurodegenerative disease that has great sufferings on patients and eventually leads to death. Early detection of AD and its prodromal stage, mild cognitive impairment (MCI) which can be either stable (sMCI) or progressive (pMCI), is highly desirable for effective treatment planning and tailoring therapy. Recent studies recommended using multimodal data fusion of genetic (single nucleotide polymorphisms, SNPs) and neuroimaging data (magnetic resonance imaging (MRI) and positron emission tomography (PET)) to discriminate AD/MCI from normal control (NC) subjects. However, missing multimodal data in the cohort under study is inevitable. In addition, data heterogeneity between phenotypes and genotypes biomarkers makes learning capability of the models more challenging. Also, the current studies mainly focus on identifying brain disease classification and ignoring the regression task. Furthermore, they utilize multistage for predicting the brain disease progression. To address these issues, we propose a novel multimodal neuroimaging and genetic data fusion for joint classification and clinical score regression tasks using the maximum number of available samples in one unified framework using convolutional neural network (CNN). Specifically, we initially perform a technique based on linear interpolation to fill the missing features for each incomplete sample. Then, we learn the neuroimaging features from MRI, PET, and SNPs using CNN to alleviate the heterogeneity among genotype and phenotype data. Meanwhile, the high learned features from each modality are combined for jointly identifying brain diseases and predicting clinical scores. To validate the performance of the proposed method, we test our method on 805 subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Also, we verify the similarity between the synthetic and real data using statistical analysis. Moreover, the experimental results demonstrate that the proposed method can yield better performance in both classification and regression tasks. Specifically, our proposed method achieves accuracy of 98.22%, 93.11%, and 97.35% for NC vs. AD, NC vs. sMCI, and NC vs. pMCI, respectively. On the other hand, our method attains the lowest root mean square error and the highest correlation coefficient for different clinical scores regression tasks compared with the state-of-the-art methods.

Biceph-Net: A Robust and Lightweight Framework for the Diagnosis of Alzheimer's Disease Using 2D-MRI Scans and Deep Similarity Learning

Attention-based and Micro Designed EfficientNetB2 for Diagnosis of Alzheimer’s Disease

Early Diagnosis of Alzheimer's Disease Using Deep Learning

AlzhiNet: Traversing from 2DCNN to 3DCNN, Towards Early Detection and Diagnosis of Alzheimer's Disease

Lightweight neural network for Alzheimer's disease classification using multi-slice sMRI

A deep learning framework for early diagnosis of Alzheimer's disease on MRI images

DenseIncepS115: a novel network-level fusion framework for Alzheimer's disease prediction using MRI images

U-net based analysis of MRI for Alzheimer’s disease diagnosis

AD-Lite Net: A Lightweight and Concatenated CNN Model for Alzheimer's Detection from MRI Images

3-1-3 Weight averaging technique-based performance evaluation of deep neural networks for Alzheimer's disease detection using structural MRI

Diagnosis and classification of Alzheimer's disease by using a convolution neural network algorithm

Deep Convolutional Neural Network based Classification of Alzheimer's Disease using MRI data

Residual-Based Multi-Stage Deep Learning Framework for Computer-Aided Alzheimer's Disease Detection

Dual Attention Aware Octave Convolution Network for Early-Stage Alzheimer's Disease Detection

Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks

Residual-Based Multi-Stage Deep Learning Framework for Computer-Aided Alzheimer’s Disease Detection

Neuro-cogniguard: a Deep Learning Approach for Early Alzheimer's Detection

Deep neural networks for the early diagnosis of dementia and Alzheimer's disease from MRI images

SNeurodCNN: Structure-focused Neurodegeneration Convolutional Neural Network for Modelling and Classification of Alzheimer's Disease

A Novel Artificial Intelligence (AI) Method to Classify and Predict the Progression of Alzheimers Disease

Alzheimer's Disease Diagnosis With Brain Structural MRI Using Multiview-Slice Attention and 3D Convolution Neural Network